William Love
Founder en DESTINY PHARMA PLC .
Fortuna: 2 M $ al 31/03/2024
Perfil
William Guy Love is the founder of Destiny Pharma Plc, a company founded in 1996.
He currently holds the title of Chief Scientific Officer & Executive Director at Destiny Pharma Plc.
In addition to his founding position, Dr. Love also held a former job as a Founding Member at Beam Alliance.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
DESTINY PHARMA PLC
6.83% | 18/10/2023 | 6 509 500 ( 6.83% ) | 2 M $ | 31/03/2024 |
Cargos activos de William Love
Empresas | Cargo | Inicio |
---|---|---|
DESTINY PHARMA PLC | Founder | 04/03/1996 |
Antiguos cargos conocidos de William Love.
Empresas | Cargo | Fin |
---|---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Destiny Pharma Plc | |
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Health Technology |
- Bolsa de valores
- Insiders
- William Love